Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aimmune Therap (AIMT)

Aimmune Therap (AIMT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,291,179
  • Shares Outstanding, K 62,669
  • Annual Sales, $ 0 K
  • Annual Income, $ -210,750 K
  • 60-Month Beta 0.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.04
  • Number of Estimates 6
  • High Estimate -0.92
  • Low Estimate -1.11
  • Prior Year -0.95
  • Growth Rate Est. (year over year) -9.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.02 +16.32%
on 01/13/20
37.00 -5.62%
on 01/16/20
+3.24 (+10.23%)
since 12/17/19
3-Month
24.81 +40.75%
on 10/18/19
37.00 -5.62%
on 01/16/20
+9.63 (+38.08%)
since 10/17/19
52-Week
16.95 +106.02%
on 07/11/19
37.00 -5.62%
on 01/16/20
+12.31 (+54.44%)
since 01/17/19

Most Recent Stories

More News
Aimmune Therapeu Has Returned 45.2% Since SmarTrend Recommendation (AIMT)

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 4 months, Aimmune Therapeu has returned 45.25% as of today's recent price of $35.92....

AIMT : 34.92 (-4.49%)
SmarTrend Watching for Potential Rebound in Shares of Aimmune Therapeu After 2.86% Loss

Aimmune Therapeu (NASDAQ:AIMT) traded in a range yesterday that spanned from a low of $30.32 to a high of $31.73. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of...

AIMT : 34.92 (-4.49%)
Is the Options Market Predicting a Spike in Aimmune Therapeutics (AIMT) Stock?

Investors need to pay close attention to Aimmune Therapeutics (AIMT) stock based on the movements in the options market lately.

AIMT : 34.92 (-4.49%)
Aimmune Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that its President and Chief Executive Officer,...

JPM : 138.20 (+0.69%)
AIMT : 34.92 (-4.49%)
Relatively Good Performance Detected in Shares of Epizyme Inc in the Biotechnology Industry (EPZM , AIMT , AKBA , ARWR, ATRA )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AIMT : 34.92 (-4.49%)
AKBA : 8.03 (+3.21%)
EPZM : 26.72 (+4.62%)
ARWR : 56.42 (-1.21%)
Aimmune Therapeu Up 32.3% Since SmarTrend Uptrend Call (AIMT)

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 4 months, Aimmune Therapeu has returned 32.27% as of today's recent price of $32.71....

AIMT : 34.92 (-4.49%)
Watch for Aimmune Therapeu to Potentially Pullback After Gaining 1.50% Yesterday

Aimmune Therapeu (NASDAQ:AIMT) traded in a range yesterday that spanned from a low of $32.44 to a high of $33.35. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

AIMT : 34.92 (-4.49%)
Uptrend Call Working As Aimmune Therapeu Stock Rises 27.6% (AIMT)

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 3 months, Aimmune Therapeu has returned 27.58% as of today's recent price of $31.55....

AIMT : 34.92 (-4.49%)
Aimmune Therapeu Has Returned 29.9% Since SmarTrend Recommendation (AIMT)

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 3 months, Aimmune Therapeu has returned 29.92% as of today's recent price of $32.13....

AIMT : 34.92 (-4.49%)
Aimmune Therapeu Rises 1.63% on Heavy Volume: Watch For Potential Pullback

Aimmune Therapeu (NASDAQ:AIMT) traded in a range yesterday that spanned from a low of $29.91 to a high of $30.92. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high...

AIMT : 34.92 (-4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AIMT with:

Business Summary

Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company's characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and...

See More

Key Turning Points

2nd Resistance Point 38.25
1st Resistance Point 36.59
Last Price 34.92
1st Support Level 33.47
2nd Support Level 32.01

See More

52-Week High 37.00
Last Price 34.92
Fibonacci 61.8% 29.34
Fibonacci 50% 26.98
Fibonacci 38.2% 24.61
52-Week Low 16.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar